Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Acquires ID Labs

NEW YORK (GenomeWeb) – Empire Genomics said on Monday that it has acquired molecular diagnostic reagents firm ID Labs for an undisclosed amount.

Based in London, Ontario, ID Labs provides antibodies, molecular probes, cytogenetics media, and other molecular biology reagents to academia, government, pharmaceutical, biotech, and hospital customers.

Empire Genomics CEO Anthony Johnson said that the deal is aligned "with our corporate strategy of complementing the product offerings for our clinical lab and customers, as well as increasing our global distribution network." He added that he expects it to be the first of several acquisitions "as we look to accelerate the growth of our business in the ever changing molecular diagnostics environment." 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.